NewLimit is a biotechnology company working to radically extend human healthspan.
We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
Yes — NewLimit has 14 open jobs on JobsRadar right now. 5 of them were opened in the last 30 days. 10 of them disclose pay, with a median of $155,000 a year and most offers between $110,625 and $176,875. The board was last refreshed on July 25, 2026 at 16:30 UTC.